scholarly article | Q13442814 |
P2093 | author name string | Kelly Bosak | |
P2860 | cites work | Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction | Q37868853 |
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 | ||
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study | Q42646355 | ||
Hypertriglyceridemia as a cardiovascular risk factor | Q44268486 | ||
Racial disparities in hypertension prevalence, awareness, and management | Q44956362 | ||
Health care utilization and costs by metabolic syndrome risk factors. | Q45951128 | ||
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes | Q46285507 | ||
Relative importance of borderline and elevated levels of coronary heart disease risk factors | Q46378847 | ||
American Heart Association and American Stroke Association national survey of stroke risk awareness among women | Q46803713 | ||
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden | Q46990706 | ||
Motivating people to move: exercise behavior research. | Q48356176 | ||
The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride | Q51567017 | ||
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 | ||
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile | Q57413955 | ||
Trajectories of Entering the Metabolic Syndrome | Q57418664 | ||
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 | Q61192532 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
The metabolic syndrome | Q29616309 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation | Q33950646 | ||
Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health | Q34207128 | ||
Nonexercise activity thermogenesis (NEAT): environment and biology | Q34315519 | ||
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? | Q34361973 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. | Q34547941 | ||
Awareness of national physical activity recommendations for health promotion among US adults | Q34856602 | ||
A practical approach to risk assessment to prevent coronary artery disease and its complications | Q35179558 | ||
Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women | Q35190542 | ||
Cardiovascular health disparities: a systematic review of health care interventions | Q36632231 | ||
A guide for developing intervention tools addressing environmental factors to improve diet and physical activity | Q36769746 | ||
Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease | Q36935040 | ||
Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment | Q37345665 | ||
Predicting the 30-year risk of cardiovascular disease: the framingham heart study | Q37356527 | ||
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. | Q37461889 | ||
P433 | issue | 8 | |
P921 | main subject | metabolic syndrome | Q657193 |
P304 | page(s) | 14-20; quiz 20-1 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | The Nurse Practitioner | Q15716745 |
P1476 | title | Managing metabolic syndrome in women | |
P478 | volume | 37 |
Q30355848 | Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR. | cites work | P2860 |
Search more.